209 related articles for article (PubMed ID: 2959356)
1. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Simon JH; Tebbi CK; Freeman AI; Brecher ML; Green DM; Sandberg AA
Cancer; 1987 Nov; 60(10):2515-20. PubMed ID: 2959356
[TBL] [Abstract][Full Text] [Related]
2. Megakaryoblastic leukemia and Down's syndrome: a review.
Zipursky A; Peeters M; Poon A
Pediatr Hematol Oncol; 1987; 4(3):211-30. PubMed ID: 2978961
[TBL] [Abstract][Full Text] [Related]
3. Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome.
Ma SK; Lee AC; Wan TS; Lam CK; Chan LC
Leukemia; 1999 Mar; 13(3):491-2. PubMed ID: 10086746
[No Abstract] [Full Text] [Related]
4. Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome.
Zipursky A; Thorner P; De Harven E; Christensen H; Doyle J
Leuk Res; 1994 Mar; 18(3):163-71. PubMed ID: 8139285
[TBL] [Abstract][Full Text] [Related]
5. Acute megakaryoblastic leukemia (FAB-M7) in an infant presenting with orbital chloroma and meningeal involvement.
Suttorp M; Polchau H; Kühn B; Löffler H; Rister M
Haematol Blood Transfus; 1990; 33():368-73. PubMed ID: 2323644
[No Abstract] [Full Text] [Related]
6. Acute megakaryoblastic leukemia and clonal trisomy 21 in a phenotypically normal infant.
Arico M
Blood; 1991 Jun; 77(11):2542-3. PubMed ID: 1828181
[No Abstract] [Full Text] [Related]
7. [Acute myeloblastic leukemia 5q-. Clinical and cytogenetic remission by means of intensive chemotherapy].
Las Heras G; Ribera JM; Granada I; Millá F
Sangre (Barc); 1991 Jun; 36(3):251-2. PubMed ID: 1948550
[No Abstract] [Full Text] [Related]
8. High leukaemia cure rate in Down's syndrome explained.
Bradbury J
Lancet Oncol; 2005 Mar; 6(3):134. PubMed ID: 15759357
[No Abstract] [Full Text] [Related]
9. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.
Ravindranath Y; Abella E; Krischer JP; Wiley J; Inoue S; Harris M; Chauvenet A; Alvarado CS; Dubowy R; Ritchey AK
Blood; 1992 Nov; 80(9):2210-4. PubMed ID: 1384797
[TBL] [Abstract][Full Text] [Related]
11. Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.
Kudo K; Hama A; Kojima S; Ishii R; Morimoto A; Bessho F; Sunami S; Kobayashi N; Kinoshita A; Okimoto Y; Tawa A; Tsukimoto I
Int J Hematol; 2010 May; 91(4):630-5. PubMed ID: 20237876
[TBL] [Abstract][Full Text] [Related]
12. An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
Kojima S; Sako M; Kato K; Hosoi G; Sato T; Ohara A; Koike K; Okimoto Y; Nishimura S; Akiyama Y; Yoshikawa T; Ishii E; Okamura J; Yazaki M; Hayashi Y; Eguchi M; Tsukimoto I; Ueda K
Leukemia; 2000 May; 14(5):786-91. PubMed ID: 10803507
[TBL] [Abstract][Full Text] [Related]
13. Dicentric chromosome in the bone marrow of a child with megakaryoblastic leukaemia and Down's syndrome.
Wilkie AO; Kitchen C; Oakhill A; Howell RT; Berry PJ
J Clin Pathol; 1988 Apr; 41(4):378-80. PubMed ID: 2966817
[TBL] [Abstract][Full Text] [Related]
14. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I;
J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827
[TBL] [Abstract][Full Text] [Related]
16. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
[TBL] [Abstract][Full Text] [Related]
17. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
[TBL] [Abstract][Full Text] [Related]
19. A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome.
Trejo RM; Aguilera RP; Nieto S; Kofman S
Cancer Genet Cytogenet; 2000 Jul; 120(2):160-2. PubMed ID: 10942809
[TBL] [Abstract][Full Text] [Related]
20. [Acute megakaryoblastic leukemia. Relation to trisomy 21].
Levaltier X; Reman O; Boutard P; Mandard JC; Troussard X; Leporrier M
Arch Fr Pediatr; 1991 Oct; 48(8):563-6. PubMed ID: 1837448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]